+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5639834
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The High-Throughput Screening Market grew from USD 23.05 billion in 2023 to USD 26.09 billion in 2024. It is expected to continue growing at a CAGR of 13.67%, reaching USD 56.53 billion by 2030.

It involves the rapid testing and analysis of many samples, enabling researchers to evaluate various compounds' effectiveness, selectivity, and potential toxicity. The primary applications of HTS are drug discovery and development in pharmaceutical and biotechnology companies, along with academic research laboratories. The rise in investment by governments and private organizations globally towards research and development activities fuels the growth of this market segment. Advances in computational biology enable researchers to analyze massive amounts of data generated by HTS systems more efficiently, which has significantly driven the market growth. However, high initial setup costs related to equipment procurement and maintenance and complexities related to data interpretation may hamper the market expansion. Expanding applications of HTS in different sectors, such as agrochemicals and environmental monitoring, will create a lucrative market opportunity in the forecasted period.

Regional Insights

The Americas experienced significant growth in high throughput screening market due to several government initiatives, patents for innovative technologies, and collaborative activities with industry partners to facilitate drug discovery through HTS. Within EU countries, HTS is being supported through initiatives funded by the European Commission research program towards advancing scientific breakthroughs and rising research and development activities by the key market vendors to optimize healthcare solutions. The Middle East and African region represents a growing market for HTS, driven mainly by investments in infrastructure development by governments seeking to improve local biotechnology capabilities. The Asia-Pacific region has observed a developing landscape due to government support by investing heavily in life sciences and pharmaceutical research and government-supported HTS advancement through funding programs such as the Japan Agency for Medical Research and Development (AMED). The rapidly growing pharmaceutical industry, fueled by strong government support in healthcare initiatives and innovation in drug discovery by providing access to HTS facilities at academic institutions, contributed to the market growth in the APAC region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the High-Throughput Screening Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing adoption of open innovation models in biotechnology and pharmaceutical companies
  • Rising applications in stem cell research

Market Restraints

  • High cost associated with the equipment procurement and maintenance

Market Opportunities

  • Increasing investment in R&D by pharmaceutical & Government authorities
  • Technological advancements high throughput screening

Market Challenges

  • Dearth of skilled operators coupled with complexities related to data interpretation

Market Segmentation Analysis

  • Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
  • Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
  • Screening Size: Utilization of 96-well format for increase in cell based studies
  • Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
  • End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the High-Throughput Screening Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the High-Throughput Screening Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services

Axxam and Promega Corporation have signed an agreement to develop smart assays for drug discovery, utilizing high-throughput screening technology. This agreement leverages Promega's expertise in assay development and combines it with Axxam's high-throughput capabilities, resulting in a more efficient and cost-effective drug discovery process.

Charles River Laboratories Acquires SAMDI Tech

Charles River Laboratories has acquired Samdi Tech to enhance CRL's product suite and expand its range of services, allowing customers to access novel technologies for improved drug discovery. Samdi Tech's advanced automated systems are specifically designed to accelerate the screening and analysis of drug compounds, resulting in faster and more accurate results.

Particle Works Launches ALiS - An Automated and High-Throughput Platform for LNP Formulation Screening

Particle Works has introduced ALIS, a high-throughput platform designed specifically for LNP formulation in High-Throughput Screening. This innovative platform offers customized formulae with various properties, including size distribution, polydispersity index, and zeta potential. Researchers can expect reduced costs and accelerated drug discovery processes by leveraging ALIS.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the High-Throughput Screening Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the High-Throughput Screening Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed Inc., AXXAM S.p.A., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Charles River Laboratories International, Inc., Corning Incorporated, Danaher Corporation, DIANA Biotechnologies, a.s., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Hamilton Company, IRBM S.p.A., Lonza Group AG, Luminex Corporation, Merck KGaA, Molecular Devices, LLC, NanoTemper Technologies GmbH, PerkinElmer, Inc., Promega Corporation, Reprocell Inc., SYGNATURE DISCOVERY LIMITED, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the High-Throughput Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product & Service

  • Consumables
  • Laboratory Equipment
  • Reagents & Assay Kits

Instruments

  • Detection Systems
  • Liquid Handling Systems
  • Services
  • Software

Screening Size

  • 12-well Format
  • 1536-well Format
  • 24-well Format
  • 384-well Format
  • 48-well Format
  • 6-well Format
  • 96-well Format
  • TechnologyCell-Based Assays
  • 2D Cell Culture
3D Cell CultureScaffold-Based Technology
  • Hydrogels
  • Alginate & Agarose

Animal-Derived Hydrogels

  • Collagen
  • Matrigel
  • Synthetic Hydrogels
  • Inert Matrix & Solid Scaffolds
  • Micropatterned Surfaces

Scaffold-Free Technology

  • Hanging-Drop Plates
  • Ultra-Low Binding Plates
  • Perfusion Cell Culture
  • Reporter-Based Assays
  • Lab-on-a-Chip Technology
  • Label-Free Technology

Application

  • Biochemical Screening
  • Drug Discovery
  • Life Sciences Research

End User

  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of open innovation models in biotechnology and pharmaceutical companies
5.1.1.2. Rising applications in stem cell research
5.1.2. Restraints
5.1.2.1. High cost associated with the equipment procurement and maintenance
5.1.3. Opportunities
5.1.3.1. Increasing investment in R&D by pharmaceutical & Government authorities
5.1.3.2. Technological advancements high throughput screening
5.1.4. Challenges
5.1.4.1. Dearth of skilled operators coupled with complexities related to data interpretation
5.2. Market Segmentation Analysis
5.2.1. Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
5.2.2. Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
5.2.3. Screening Size: Utilization of 96-well format for increase in cell based studies
5.2.4. Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
5.2.5. End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. High-Throughput Screening Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Services
6.5. Software
7. High-Throughput Screening Market, by Screening Size
7.1. Introduction
7.2. 12-well Format
7.3. 1536-well Format
7.4. 24-well Format
7.5. 384-well Format
7.6. 48-well Format
7.7. 6-well Format
7.8. 96-well Format
8. High-Throughput Screening Market, by Technology
8.1. Introduction
8.2. Cell-Based Assays
8.3. Lab-on-a-Chip Technology
8.4. Label-Free Technology
9. High-Throughput Screening Market, by Application
9.1. Introduction
9.2. Biochemical Screening
9.3. Drug Discovery
9.4. Life Sciences Research
10. High-Throughput Screening Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Americas High-Throughput Screening Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific High-Throughput Screening Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa High-Throughput Screening Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services
14.3.2. Charles River Laboratories Acquires SAMDI Tech
14.3.3. Particle Works Launches ALiS - An Automated and High-Throughput Platform for LNP Formulation Screening
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. HIGH-THROUGHPUT SCREENING MARKET RESEARCH PROCESS
FIGURE 2. HIGH-THROUGHPUT SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HIGH-THROUGHPUT SCREENING MARKET DYNAMICS
FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 12-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 12-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 24-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 24-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 48-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 48-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 6-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 6-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL FORMAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL FORMAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 2D CELL CULTURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 2D CELL CULTURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ALGINATE & AGAROSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ALGINATE & AGAROSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COLLAGEN, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MATRIGEL, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MATRIGEL, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INERT MATRIX & SOLID SCAFFOLDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INERT MATRIX & SOLID SCAFFOLDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROPATTERNED SURFACES, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROPATTERNED SURFACES, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HANGING-DROP PLATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HANGING-DROP PLATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ULTRA-LOW BINDING PLATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ULTRA-LOW BINDING PLATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PERFUSION CELL CULTURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PERFUSION CELL CULTURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER-BASED ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER-BASED ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY BIOCHEMICAL SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY BIOCHEMICAL SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIFE SCIENCES RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIFE SCIENCES RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 105. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 106. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 107. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 108. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 109. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 110. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 111. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 112. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 113. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 114. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 115. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 116. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 117. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 118. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 119. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 120. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 121. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 124. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 125. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 126. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 127. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 128. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 129. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 130. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 131. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 132. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 133. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 140. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 141. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 142. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 143. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 144. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 145. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 146. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 147. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 148. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 149. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 152. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 153. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 154. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 155. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 158. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 159. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 160. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 161. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 166. ARGENTINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 167. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 168. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 169. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 170. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 171. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 172. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 173. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 174. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 175. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 176. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 177. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 178. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 179. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 180. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 181. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 182. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 183. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 184. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 185. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 186. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 187. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 194. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 195. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 196. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 197. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 198. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 199. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 200. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 201. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 202. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 203. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 204. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 205. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 206. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 207. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 210. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 211. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 212. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 213. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 214. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 215. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 218. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 219. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 220. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 221. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 222. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 223. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 224. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 225. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 226. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 227. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 230. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 231. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 232. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 233. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 236. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 237. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 238. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 239. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 246. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 247. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 248. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 249. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 250. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 251. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 252. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 253. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 256. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 257. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 258. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 259. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 262. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 263. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 264. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 265. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 266. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 267. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 270. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 271. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 272. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 274. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 276. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 278. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 280. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2023 (USD MILLION)
TABLE 284. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2024-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2018-2023 (USD MILLION)
TABLE 286. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 3D CELL CULTURE, 2024-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 288. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-BASED TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2018-2023 (USD MILLION)
TABLE 290. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HYDROGELS, 2024-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2018-2023 (USD MILLION)
TABLE 292. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ANIMAL-DERIVED HYDROGELS, 2024-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCAFFOLD-FREE TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 298. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 300. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 301. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
TABLE 302. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
TABLE 303. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 304. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 305. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 306. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 307. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2018-2023 (USD MILLION)
TABLE 308. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING SIZE, 2024-2030 (USD MILLION)
TABLE 309. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 310. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 311. AUSTRALIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY C

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • AXXAM S.p.A.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • BMG LABTECH GmbH
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • DIANA Biotechnologies, a.s.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Hamilton Company
  • IRBM S.p.A.
  • Lonza Group AG
  • Luminex Corporation
  • Merck KGaA
  • Molecular Devices, LLC
  • NanoTemper Technologies GmbH
  • PerkinElmer, Inc.
  • Promega Corporation
  • Reprocell Inc.
  • SYGNATURE DISCOVERY LIMITED
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information